Deutsche Bank AG Acquires Shares of 451,372 HCA Healthcare, Inc. $HCA

Key Points

• Deutsche Bank AG acquired 451,372 HCA Healthcare shares in the second quarter, worth approximately $176 million and representing about 0.21% of the company. Institutional investors collectively own 62.73% of HCA’s stock.
• HCA reported quarterly revenue of $20.23 billion, up 8.7% year over year, and earnings of $7.59 per share, slightly exceeding analyst expectations.
• HCA declared a quarterly dividend of $0.78 per share, equal to an annualized $3.12 and a 0.8% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $465.59.

Deutsche Bank AG bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 451,372 shares of the company's stock, valued at approximately $175,985,000. Deutsche Bank AG owned about 0.21% of HCA Healthcare as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Norges Bank purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,262,513,000. Life Cycle Investment Partners Ltd bought a new position in HCA Healthcare during the fourth quarter valued at about $374,037,000. Viking Global Investors LP increased its holdings in HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock worth $717,214,000 after buying an additional 690,773 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company's stock valued at $309,686,000 after acquiring an additional 649,058 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $147,944,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Up 1.8%

Shares of HCA opened at $412.27 on Wednesday. The business's 50-day moving average price is $395.07 and its 200-day moving average price is $445.35. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The stock has a market cap of $89.26 billion, a PE ratio of 13.80, a P/E/G ratio of 1.40 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion during the quarter, compared to analysts' expectations of $19.76 billion. During the same quarter in the previous year, the company earned $6.84 earnings per share. HCA Healthcare's revenue for the quarter was up 8.7% on a year-over-year basis. Analysts expect that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare's dividend payout ratio (DPR) is currently 10.45%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. JPMorgan Chase & Co. reduced their price objective on HCA Healthcare from $535.00 to $490.00 and set a "neutral" rating for the company in a report on Tuesday, May 19th. Sanford C. Bernstein reiterated a "market perform" rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Robert W. Baird lowered their price objective on HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating on the stock in a research note on Monday, July 27th. Deutsche Bank Aktiengesellschaft set a $476.00 target price on shares of HCA Healthcare in a research report on Monday, July 27th. Finally, Barclays dropped their price target on shares of HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating on the stock in a research note on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $465.59.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source